10:14 AM EST, 01/16/2025 (MT Newswires) -- Guardant Health ( GH ) said Thursday it is partnering with ConcertAI to combine patient electronic medical records with their genomic and epigenomic tumor profiling data throughout their health care treatments for cancer.

Financial terms and other details of the agreement were not disclosed.

Concert AI is an oncology data and artificial intelligence software-as-a-service company.

Shares of Guardant Health ( GH ) were down more than 1% in recent trading activity.

Price: 37.01, Change: -0.49, Percent Change: -1.32